| Value | ₹1.51 Cr |
|---|
BSE filing, NSE: VENMAX. Summary written from the filing by ALFA Finder's alert engine.
Venmax Drugs & Pharmaceuticals Ltd: key numbers
- Share price
- ₹14.23
- Market cap
- ₹12.50 Cr
- Revenue (annual)
- ₹8.02 Cr
- Net profit (annual)
- ₹0.25 Cr
- P/E (TTM)
- 44.6×Sector 42.0×
- Promoter holding
- 10.46%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Venmax Drugs & Pharmaceuticals Ltd
All →Venmax Drugs & Pharmaceuticals Board Meeting Date
Venmax Drugs and Pharmaceuticals will hold a board meeting on November 12, 2026 to consider unaudited standalone results for the quarter ended September 30, 2026. The trading window stays closed until November 14, 2026.
Venmax Drugs & Pharmaceuticals Acquisition
Venmax Drugs' shareholders met on 24 October 2026 under an NCLT order to approve an amalgamation with Hatri Pharma. Voting results await the scrutinizer's report.
Venmax Drugs & Pharmaceuticals Other Announcement
The company filed its quarterly shareholding pattern under Regulation 31(1)(b) of the SEBI LODR Regulations for the quarter ended September 30, 2026.
Venmax Drugs & Pharmaceuticals Annual General Meeting
Venmax Drugs and Pharmaceuticals held its 37th Annual General Meeting on September 26, 2026. Shareholders considered the financial statements and various directorship appointments.
Venmax Drugs & Pharmaceuticals Acquisition
Venmax Drugs and Pharmaceuticals Limited announced an NCLT-convened meeting of equity shareholders on October 24, 2026, to consider the proposed merger with Hatri Pharma Private Limited.
Venmax Drugs & Pharmaceuticals Acquisition
NCLT Hyderabad directed Venmax to convene a shareholder meeting on 24 Oct 2026 for the amalgamation of Hatri Pharma into Venmax. The order also dispensed with meetings of Hatri Pharma's shareholders and creditors.
Other capital structure change announcements
All →Manaksia Coated Metals & Industries Capital Structure Change
Manaksia Coated closed its QIP, allotting 1,19,99,847 shares at Rs 125 each. The issue totals about Rs 150 crore, priced 1.58% below floor.
- Value
- ₹150.0 Cr
Great Eastern Shipping Company Capital Structure Change
Great Eastern Shipping bought back 1,92,000 equity shares on 05-11-2026 at an average of ₹1,507.08, worth about ₹28.94 Cr. Cumulative buyback reached 40,40,694 shares.
- Value
- ₹28.94 Cr
VANS Electroengineerings Capital Structure Change
Vans Electroengineerings approved an investment of up to Rs 5 Crore in subsidiary Infowin Electric via equity subscription, lifting its stake from 67% to 80%. The same board meeting also approved a Rs 10 Crore loan to Infowin and an EOGM.
- Value
- ₹5.00 Cr
- Execution
- Maximum four months from 05-11-2026 (board approval date)
Dev Labtech Venture Capital Structure Change
Dev Labtech's shareholders approved raising authorised share capital from ₹25 Crore to ₹31 Crore at an EGM on 5 November 2026. The Memorandum capital clause is amended.
DCW Capital Structure Change
DCW Limited reported buying back 125,697 equity shares on 5 November 2026 at an average price of Rs 46.84 through the open market. Cumulative shares bought back under the programme reached 4,35,798.
- Value
- ₹0.59 Cr
Man Infraconstruction Capital Structure Change
Man Infraconstruction bought back 1,00,000 shares on NSE on 5 November 2026 at an average Rs.111.49. The cumulative buyback stands at 1,07,40,000 shares.
- Value
- ₹1.11 Cr